Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › UTHR

SUPERSTRING CAPITAL MANAGEMENT LP position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 7,172 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 2.45% of its reported portfolio and ranking #16 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed UTHR holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)7.17K sh
Reported value held$3.89M
Portfolio Weight2.45%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's UTHR position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in UTHR in Q2 2025 at 4,874 shares (US$1.4M). The position peaked in Q4 2025 at 9,451 shares, worth US$4.6M. Across 4 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,172 shares valued at US$3.9M — an increase of 1,986 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2026 (shares fell 9% over the following quarter), a 38% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 4.87K $1.40M New
Q4 2025 9.45K $4.61M New
Q1 2026 5.19K $3.08M Reduce
Q2 2026 7.17K $3.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held UTHR?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed UTHR holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in UTHR?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 7.17K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $3.89M, representing 2.45% of its reported portfolio and ranking #16.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling UTHR?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in UTHR. The position peaked in Q4 2025 at 9.45K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.